FPH.NZ : Summary for Fisher & Paykel Healthcare Corp - Yahoo Finance

U.S. Markets open in 9 hrs 1 mins

Fisher & Paykel Healthcare Corporation Limited (FPH.NZ)

NZSE - NZSE Delayed Price. Currency in NZD
Add to watchlist
8.75-0.04 (-0.46%)
At close: 5:00PM NZDT
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close8.79
Bid8.75 x
Ask8.92 x
Day's Range8.75 - 8.95
52 Week Range8.13 - 10.93
Avg. Volume1,180,538
Market Cap4.96B
PE Ratio (TTM)31.47
Earnings DateN/A
Dividend & Yield0.16 (2.52%)
Ex-Dividend DateN/A
1y Target EstN/A
  • Reuters26 days ago

    New Zealand's F&P Healthcare considers ways around proposed Trump tariffs on Mexico

    New Zealand medical device firm Fisher & Paykel Healthcare will consider switching factories making products bound for the United States from Mexico to New Zealand if U.S. President Donald Trump's administration taxes Mexican imports. The company, a major global supplier of specialized respiratory equipment for hospitals, is one of the first companies with Mexican operations to disclose how it would respond to the Trump administration's proposed tariff on imports from across the U.S. southern border. Shifting production to New Zealand could raise production costs, said Fisher & Paykel Healthcare's chief executive Lewis Gradon.

  • Reuters3 months ago

    Fisher & Paykel wins German court case against ResMed

    Fisher & Paykel Healthcare Corporation Ltd said on Friday a German court has overturned both preliminary injunctions granted to ResMed Inc , which had taken legal action against the New Zealand-based medical device maker. It was last up 4.9 percent at NZ$8.610, having lost more than 21 percent since ResMed's legal action on Aug.18. ResMed in August moved against Fisher & Paykel in the United States, Germany and New Zealand to stop alleged infringement of its patented technology.

  • PR Newswire4 months ago

    New Research Shows Benefits of Fisher & Paykel Healthcare's Optiflow™ Nasal High Flow Therapy

    AUCKLAND, New Zealand, Oct. 14, 2016 /PRNewswire/ -- Fisher & Paykel Healthcare (NZX: FPH, ASX: FPH) today welcomed new research on the benefits of its Optiflow™ nasal high flow therapy. This research ...